The genetic background is different between populations. The outcome of a genetic mutation can be very different between Westerners and Easterners. Instead of repeating the experiments and clinical trials done on Westerners once again on Easterners, we should increasingly rely on artificial intelligence to predict the possible outcomes, leveraging the differences at multiple levels of omics. With the accumulated experience and data primarily from the Chinese market, Dr. Luo is currently working on extending the role of artificial intelligence in a Chinese version of precision medicine with high-speed and accuracy.